CXM: financial statements from SEC

Income statement

Metric	Apr 30, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Oct 31, 2024	Jul 31, 2024
Revenue	219m	219m	212m	206m	201m	197m
Cost of revenue	76m	74m	67m	63m	58m	54m
Gross profit	143m	145m	145m	143m	143m	143m
Research and development	23m	25m	23m	23m	23m	23m
Selling, general and administrative	35m	34m	36m	34m	34m	39m
Operating expenses	132m	134m	128m	145m	135m	143m
Operating income	11m	12m	16m	−2m	8m	−87,000
Pre-tax income	16m	17m	24m	5m	13m	6m
Income tax	12m	14m	11m	7m	3m	4m
Net income	4m	3m	13m	−2m	10m	2m
Earnings per share	0.02	0.01	0.05	−0.01	0.04	0.01
Earnings per share, diluted	0.02	0.01	0.05	−0.01	0.04	0.01
Weighted average shares	241m	245m	254m	257m	254m	261m
Weighted average shares, diluted	243m	252m	263m	257m	262m	272m

Metric	Apr 30, 2026	Jan 31, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024
Cash and equivalents	163m	163m	190m	125m	126m	145m	102m	127m
Receivables	196m	278m	150m	202m	203m	286m	174m	189m
Current assets	745m	888m	736m	767m	862m	854m	730m	742m
Property, plant and equipment	34m	33m	33m	32m	31m	32m	33m	34m
Total assets	1.06bn	1.21bn	1.05bn	1.09bn	1.19bn	1.18bn	970m	984m
Current liabilities	520m	554m	444m	494m	495m	518m	419m	459m
Total liabilities	573m	612m	496m	543m	550m	572m	473m	515m
Equity	488m	593m	558m	543m	640m	612m	497m	469m
Treasury shares	0	14m	14m	14m	14m	14m	14m	14m

Metric	Apr 30, 2026	Apr 30, 2025
Operating cash flow	70m	84m
Depreciation and amortisation	4m	5m
Share-based compensation	20m	21m
Capital expenditure	328,000	289,000
Investing cash flow	55m	−108m
Share buybacks	125m	0
Financing cash flow	−125m	3m